Does ICOSAPENT ETHYL Cause Therapy cessation? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Therapy cessation have been filed in association with ICOSAPENT ETHYL (Icosapent Ethyl). This represents 0.3% of all adverse event reports for ICOSAPENT ETHYL.
11
Reports of Therapy cessation with ICOSAPENT ETHYL
0.3%
of all ICOSAPENT ETHYL reports
0
Deaths
1
Hospitalizations
How Dangerous Is Therapy cessation From ICOSAPENT ETHYL?
Of the 11 reports, 1 (9.1%) required hospitalization, and 1 (9.1%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ICOSAPENT ETHYL. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does ICOSAPENT ETHYL Cause?
Product odour abnormal (911)
Product physical issue (666)
Poor quality product administered (452)
Off label use (416)
Product taste abnormal (414)
Drug ineffective (275)
Eructation (245)
Nausea (236)
Prescribed underdose (234)
Diarrhoea (230)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which ICOSAPENT ETHYL Alternatives Have Lower Therapy cessation Risk?
ICOSAPENT ETHYL vs IDARUBICIN
ICOSAPENT ETHYL vs IDARUCIZUMAB
ICOSAPENT ETHYL vs IDECABTAGENE VICLEUCEL
ICOSAPENT ETHYL vs IDELALISIB
ICOSAPENT ETHYL vs IDURSULFASE